UL Solutions' financial strength is strong, as evidenced by its investment-grade credit rating. Total gross debt outstanding totaled nearly $750 million as of year-end 2024. The debt structure is ...

Narrow-moat-rated Repligen is a leading provider of bioprocessing solutions for companies that manufacture biologic drugs. Its business lines include advanced filtration and fluid management systems ...

BLCO may be sold in 2025 to service the debt of majority shareholder BHC, and any sale will be at a premium to the current ...

Maintaining a healthy lifestyle has become increasingly challenging in today’s fast-paced world. Environmental pollutants, ...